GGrantIndex
Sort

51,593 grants matching hepatitis

Regulation of Normal and Asthmatic Lung Function by G-Protein-Coupled Receptors

$693,754
Kirk Druey · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI

Police Training to Reduce Occupational Needlesticks and HIV among Substance Users

$693,681
Steffanie A Strathdee · University Of California, San Diego · R01 · FY2015 · DA

Glycoprotein Remodeling in the Vasculopathy and Coagulopathy of Sepsis

$693,643
Jamey Marth · University Of California Santa Barbara · R01 · FY2017 · HL

Exercise Dose-Response Effects in Prediabetes:Responses and Mechanisms

$693,635
William E Kraus · Duke University · R01 · FY2010 · DK

The Staying Safe Intervention: Preventing HCV among Young Opioid Injectors

$693,559
Pedro Mateu-Gelabert · Graduate School Of Public Health And Health Policy · R01 · FY2020 · DA

Evaluation of a community-based education, navigation, and support (CENS) intervention to reduce opioid-related harms among military veterans

$693,531
Alexander S Bennett · New York University · R01 · FY2022 · DA

STD and AIDS Research Training Grant

$693,262
Sheila A. Lukehart · University Of Washington · T32 · FY2015 · AI

Pathogenesis of Dyslipidemia and Atherosclerosis in the Diabetic State

$693,205
Sudha B Biddinger · Boston Children'S Hospital · R01 · FY2024 · HL

Exosomal biomarkers for the early detection of hepatocellular carcinoma

$693,134
Ajay Goel · Beckman Research Institute/City Of Hope · R01 · FY2024 · CA

Clinical Resource for Alcoholic Hepatitis Inestigation

$693,127
Zhaoli Sun · Johns Hopkins University · R24 · FY2022 · AA

HEPATITIS C VIRUS PERSISTENCE AND PATHOGENESIS

$693,015
University Of Southern California · U19 · FY2002 · AI

Vitamin A metabolism in the adult lung

$692,990
Igor Shmarakov · Rutgers, The State Univ Of N.J. · R01 · FY2024 · HL

Role of estrogen formulation and route of delivery on skeletal outcomes in functional hypothalamic amenorrhea

$692,843
Madhusmita Misra · University Of Virginia · R01 · FY2025 · HD

Perfluoroalkyl Substances (PFASs) and Liver Cancer Risk in the United States

$692,822
Xuehong Zhang · Yale University · U01 · FY2024 · CA

Deep Phenotyping of Human Knockouts and Population Studies of the APOC3 Pathway

$692,812
Daniel James Rader · University Of Pennsylvania · R01 · FY2019 · HL

Role of a Novel Hormone Complex, Fabkin, in Dyslipidemia and Inflammation in Atherosclerosis

$692,742
Gokhan S Hotamisligil · Harvard University D/B/A Harvard School Of Public Health · R01 · FY2025 · HL

Colorado Center of Childhood Liver Disease Research Network

$692,742
Ronald J Sokol · University Of Colorado Denver · U01 · FY2017 · DK

Determinants of pegivirus persistence and immune control

$692,689
Adam Lee Bailey · University Of Wisconsin-Madison · R01 · FY2025 · AI

Correlates of protective immunity to HCV and rational vaccine design: Project 3

$692,666
Rama Rao Amara · Emory University · U19 · FY2021 · AI

Impact of Drug Policy Reform on the HIV Risk Environment among IDUs in Tijuana

$692,590
Steffanie A Strathdee · University Of California, San Diego · R37 · FY2017 · DA

Oxytocin as a Neuroendocrine Therapy for Obesity in Youth

$692,474
Elizabeth Austen Lawson · Massachusetts General Hospital · R01 · FY2024 · DK

Integrated software application for management of Hepatitis C Virus data

$692,375
Johanna C Craig · Gataca, Llc · R44 · FY2012 · AI

HIV, HCV and the Menopausal Transition: Effects on Steatosis and Fibrosis Progression

$692,364
Phyllis C Tien · Northern California Institute/Res/Edu · R01 · FY2017 · DK

Center for Humanized Mice

$692,358
Larisa Y Poluektova · University Of Nebraska Medical Center · R24 · FY2015 · OD

Nutrient Overload, Insulin Resistance, and Hepatic Mitochondrial Dysfunction

$692,311
Elizabeth Jane Parks · University Of Missouri-Columbia · R01 · FY2020 · DK